• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Top of Page
    Top of Page

    2004

    Provider Advisories

    2012

    Date

    Number

    Subjects

    Targeted Provider

    ​June 27, 2012 ​113 Preferred Drug List July 1, 2012 ​Prescribers and Pharmacies
    June 8, 2012 112 Updates to List of Brand Drugs Preferred vs Generics on the Maryland Medicaid Preferred Pharmacies and Prescribers
    May 30, 2012 111 Lipitor No Longer Brand Preferred on Maryland Medicaid Preferred Drug List Prescribers and Pharmacies
    April 25, 2012 110 Medicaid Prefers Brands Lexapro and Geodon Pharmacies and Prescribers
    February 3, 2012 109 Medicaid Temporarily Authorizes Brand Prevacid Solutabs Prescribers and Pharmacies
    January 4, 2012 108 Late Refills for HIV Drugs - Again Pharmacies

    2011

    Date

    Number

    Subjects

    Targeted Provider

    February 3, 2012 ​109 Medicaid Temporarily Authorizes Brand Prevacid Solutabs ​Prescribers and Pharmacies
    ​​ January 4, 2012 ​108 Late Refills for HIV Drugs - Again ​Pharmacies
    December 29, 2011 107 Preferred Drug List Update Pharmacies and Prescribers
    December 29, 2011 106 Cost of Dispensing Analysis Pharmacies
    December 21, 2011 105 Pharmacies
    December 20, 2011 104 Pharmacies
    December 20, 2011 103 Pharmacies
    December 13, 2011 102 Prescribers and Pharmacies
    December 5, 2011 101 Pharmacies
    November 30, 2011 100 Pharmacies
    November 4, 2011 99 Pharmacies and Prescribers
    October 7, 2011 98 Pharmacies and Prescribers
    June 30, 2011 97 Pharmacies and Prescribers
    June 29, 2011 96 All Pharmacies
    June 28, 2011 95 Pharmacies and Prescribers
    June 27, 2011 94 Pharmacies
    June 23, 2011 93 Physicians and Pharmacies
    May 13, 2011 92 Pharmacies
    May 13, 2011 91 Prescribers and Pharmacies
    April 29, 2011 90 Pharmacies
    March 23, 2011 89 Pharmacies and Prescribers
    February 25, 2011 88 Pharmacies and Prescribers

    2010

    Date

    Number

    Subjects

    Targeted Provider

    September 30, 2010 87 Prescribers and Pharmacies
    September 30, 2010 86 Prescribers and Pharmacies
    July 19, 2010 85 Prescribers and Pharmacies
    June 28, 2010 84 Prescribers and Pharmacies
    April 16, 2010 83 Limited Coverage of OTC Drugs for Dual Eligibles Prescribers and Pharmacies
    April 1, 2010 82 Few Exceptions to Generic Substitution Prescribers and Pharmacies
    March 31, 2010 81 Preferred Drug List Effective April 1, 2010 Prescribers and Pharmacies
    March 1, 2010 80 Over the Counter Plan B Coverage Pharmacies
    February 9, 2010 79 Rubber Stamped Prescribed Are Invalid Prescribers and Pharmacies
    January 26 78 Effective handling of Claim Rejections Pharmacies

    2009

    Date

    Number

    Subjects

    Targeted Provider

    December 18 77 Holiday Closings Pharmacies and Prescribers
    October 9 76 Update on mass Adjustments of legend Insulins Pharmacies
    October 1 75 Over-the-Counter Plan B Coverage Up-Date Pharmacies
    October 2 74 Some Multisource Brand Name Drugs Preferred Over Generics Pharmacies and Prescribers
    October 1 73 Preferred Drug List Effective October 1, 2009 Pharmacies and Prescribers
    October 1 72 Changes for the Status of Antipsychotic Medication on Preferred Drug List Prescribers
    September 30 71 30-Day Emergency Supply of Atypical Antipsychotics Pharmacies
    September 24 70 Mass Adjustment for Legend Insulins Pharmacies
    June 29 69 Changes in Mental Health Carve Out Pharmacies and Prescribers
    May 19 68 New Denial Codes for Non-rebatable Drugs, DESI and Obsolete Drugs Pharmacies
    April 22 67 Not all Generics are Preferred Pharmacies and Prescribers
    April 9 66 Preferred Drug List Effective April 1, 2009 Pharmacies and Providers
    April 7 65 Maryland Medicaid May Cover up to a 30-day Emergency Supply of Atypical Antipsychotics Pharmacies
    March 24 64 Time Limit Extended for Filing Claims Pharmacies
    February 18 63 Prescriber NPI Required on Pharmacy Claims, Effective March 1, 2009 Prescribers
    February 18 62 Claim Must Have Prescriber NPI Pharmacies

    2008

    Date

    Number

    Subjects

    Targeted Provider

    December 22 61 Pharmacy Hotline Holiday Schedule Pharmacies
    December 9 60 Depo-medroxyprogesterone Pharmacies
    December 1 59 Payments Delayed One Week Pharmacies
    September 24 58 30-day Emergency Supply May be Available for Atypical Antipsychotic Prescriptions Pharmacies
    September 22 57 Required Tamper-resistant Pad Features Effective October 1, 2008 Pharmacies
    September 22 56 Required Tamper-resistant Prescription Pad Features Effective October 1, 2008 Prescribers
    September 18 55 Automatic Correction of Underpayments for CellCept, Lunesta, Xopenex, Fuseon kit and Travatan Z Claims Pharmacies
    September 12 54 Scheduled Down Time for Medicaid Claims Processing System Pharmacies
    August 20 53 Physician Administered Medications Prescribers
    July 16 52 Intervention Codes Pharmacies
    July 15 51 Pain Management Agreements Prescribers
    June 25 50 Information about Formularies, PDL and PAs at Epocrates.com and DHMH website Prescribers and Pharmacies
    May 2 49 Prescriber NPI Pharmacies
    April 11 48 POS System Maintenance Pharmacies
    April 3 47 Preferred Drug List, effective April 1, 2008 Prescribers and Pharmacies
    March 26 46 NPI Information for Prescribers Prescribers and Pharmacies
    March 7 45 Tamper Resistant Prescription Pad Features to be Phased in Beginning April 1, 2008 Prescribers and all Pharmacies
    February 26 44 Reminder: At Least One Recognized Tamper Resistant Feature Required as of April 1, 2008 on all Written Medical Prescriptions Prescribers and all Pharmacies
    February 12 43 Temporary Technical Difficulty Processing Medstar Family Choice Claims All Pharmacies
    February 6 42 March 1- NPI Required on Claims Providers

    2007

    Date

    Number

    Subjects

    Targeted Provider

    December 27 41 Atypical Antipsychotics, Zyprexa Step Therapy, AIDS/HIV Drugs Carved Out from MCOs, Refills of Controlled Drugs Providers and Prescribers
    October 1 40 Tamper-Resistant Prescription Pads Are Delayed Until April 1, 2008 Prescribers and all Pharmacies
    August 29 39 Changes to Preferred Drug List Prescribers and all Pharmacies
    May 9 38 Correction of Underpayments, Over-the-Counter Plan B Coverage, Clinical Criteria for Cymbalta, Coordination of Benefits Prescribers and all Pharmacies
    Apr. 12 37 Possible Underpayments, Unacceptable Prescriber DEA Numbers, Early Refills for Recently Discharged Long Term Care Prescribers and all Pharmacies
    Mar. 28 36 Explanations of Some Claim Rejection Messages,New EVS Inquiry Phone Number, NPI Reminder, and Changes to Preferred Drug List (PDL) effective April 2007 All Pharmacies
    Feb. 9 35 Late Payments All Pharmacies
    Feb. 5 34 New Medicaid POS Claims Processor All Pharmacies
    Jan. 24 33 POS System To Be Shutdown: New Fax Numbers for PAs All Pharmacies
    Jan. 17 32 Reminder - POS Provider Training All Pharmacies

    2006

    Date

    Number

    Subjects

    Targeted Provider

    Dec. 21 31 New POS Processor; Zocor®; Prescription Transfers; Part D Questions All Pharmacies
    Oct. 5 30 Pharmacy Dispensing Fee Survey All Pharmacies
    Sept. 27 29 Changes to the Preferred Drug List; New EVS System; Narrow Therapeutic Index Drugs Prescribers and all Pharmacies
    July 28 28 Brand Name PDL Anomalies Useful Medicare Part D Phone Numbers Prescribers and all Pharmacies
    June 29 27 New Primary Adult Care Prescribers and all Pharmacies
    May 11 26 New Primary Adult Care Program (PAC) Medicare Part D Exception and Prior Authorization Request Form Prescribers and all Pharmacies
    March 23 25 Revised Preferred Drug List Transition from Pharmacy Assistance to Medicare Part D Prescribers and All Pharmacies
    March 2 24 Dummy DEA Numbers Medicare Pare D Issues All Pharmacies
    Feb. 22 23 Changes to the Preferred Drug List (PDL) Effective April 2006 Prescribers and all Pharmacies
    Jan 10. 22 Useful Medicare Phone Numbers & Medicaid Coverage of Drug Classes Excluded from Medicare Part D Basic Plans All Pharmacies

    2005

    Date

    Number

    Subjects

    Targeted Provider

    Dec. 16 21A Temporary Suspension of Early Refill Edits for Medicare Recipients Prescribers
    Dec. 14 21 Temporary Suspension of Early Refill Edits for Medicare Recipients All Pharmacies
    Nov. 23 20 Medicare Part D Prescribers and all Pharmacies
    Sept. 16 19 Changes to the Preferred Drug List (PDL) Step Therapy for Stimulants and Related Agents Revised Quantity Limits for Emend Prescribers and all Pharmacies
    Sept. 12 18 Hurricane Katrina Evacuees and Maryland Medicaid Program Prescribers and all Pharmacies
    June 23 (Revised June 28) 17 Revised Preferred Drug List Special Grandfathering for Norvasc, Coreg and Zetia Safety Concerns for Certain Generics Antimigraine (Triptan) Quantity Limits Prescribers and all Pharmacies
    April 28 16 Claims Processing Upgrade Notes All Pharmacies
    April 13 15 Planned Claims Processing System Maintenance All Pharmacies
    March 1 14 Further Clarification: Atypical Antipsychotic Dose Optimization Appropriate Use of Palladone Grandfathering Non-Preferred Mental Health Drugs Prescribers and all Pharmacies

    Date

    Number

    Subjects

    Targeted Provider

    Dec. 7 13 Dose Optimizing: Quantity limits for Atypical Antipsychotic Agents Prescribers and all Pharmacies
    Nov. 5 12 New cost Containment Initiatives Prescribers and all Pharmacies
    Oct. 27 12 PDL: The secont year Prescribers and all Pharmacies
    Oct.6 10 MedWatch Requirement for Brand Medically Necessary Prescriptions Prescribers and all Pharmacies
    July. 1 9 PDL Update: Unnecessary Prior Authorization Requests: Instructions for the Pharmacist Prescribers and all Pharmacies
    June 10 8 Changes to Pharmacy Dispensing and Recipient Co-Payments All Pharmacies
    May 5 7 PDL Update: Non-preferred Generics; Grandfathering; Exceptions to the 3-Day Emergency Rule; Step Therapy for Phosphate Binders; and Coverage of OTC's Prescribers and all Pharmacies
    Jan 30 6 Changes in Estimated Acquisition Cost and PDL Compliance Issue Community Pharmacies
    Jan 8 5 Preferred Drug List (PDL): Latest Cumulative Update on Therapeutic Classes Long-term Care Pharmacies
    Jan 8 5 Preferred Drug List (PDL): Latest Cumulative Update on Therapeutic Classes Long-term Care Pharmacies

    2003

    Date

    Number

    Subjects

    Targeted Provider

    Dec. 12 4 Revised Preferred Drug List (PDL): Cumulative Update for Prescribers Prescribers
    Nov. 3 3 Preferred Drug List (PDL Implementation) PDL Instructions for the Prescriber Prescribers
    Oct. 31 2 Preferred Drug List (PDL Implementation) PDL Instructions for the Pharmacist Community Pharmacies
    Oct. 9 1 Change in Pharmacy Assistance Co-pay Community Pharmacies